Senolytics and Immune Aging
Can senolytic treatments improve immune function as people age while preserving protection against disease?
Following this cluster can help readers distinguish preliminary findings about senolytic effects from evidence of meaningful improvements in immune health.
Where it stands now
Main bottleneck
Current evidence includes a preliminary placebo-controlled study in middle-aged humans, but does not establish whether senolytic effects translate into sustained, safe improvements in immune function.
Watch next
Controlled human evidence linking verified senolytic effects to measurable improvements in immune function, with follow-up assessing durability and adverse effects.
Progress timeline
How the evidence has changed over time.
2025 · 1 update
- Did this herbal extract change aging-related immune cells?Research note 3 of 3 · Source date 2025-02-13
Since the previous research note · Earlier expectation not tested
Track continuity
Since the previous research note: Can removing cells that have permanently stopped dividing help fight infection?
Previous expectation: Senolytic treatment might help older adults recover from infections with less inflammatory injury while preserving lasting immune protection.
What this study adds: This February 2025 paper reports an eight-week randomized human study of a plant extract in adults aged 40–59, with no significant overall immune-cell endpoint benefit and a narrower male subgroup finding. These cellular observations do not test infection recovery, tissue repair or durable protective memory.
Current research note
2023 · 2 updates
- Could removing senescent cells help an aging immune system?Research note 1 of 3 · Source date 2023-05-03
- Can removing cells that have permanently stopped dividing help fight infection?Research note 2 of 3 · Source date 2023-10-10
Since the previous research note · Earlier expectation not tested
Track continuity
Since the previous research note: Could removing senescent cells help an aging immune system?
Previous expectation: Removing harmful senescent-cell activity before vaccination might improve protection in older adults if benefit and safety were demonstrated.
What this study adds: The October 2023 review connects direct drug effects and an aged-mouse influenza example to a specific concern about memory formation and later immune recall. It does not establish whether pre-vaccination treatment improves protection in older adults.
Current research note
How this Track works
This page changes as new evidence arrives. Open any update to see what researchers found at that point in the story.